Review



complete blood counts total c7  (Assaypro)


Bioz Verified Symbol Assaypro is a verified supplier
Bioz Manufacturer Symbol Assaypro manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 91
      Buy from Supplier

    Structured Review

    Assaypro complete blood counts total c7
    Fig. 2. Reduced levels of complement component 7 complexes in active Long Covid. (A) Schematic of terminal complement complexes. (B) Complement component 7 <t>(C7)</t> complexes in log10-transformed relative fluorescence units (log10RFU), measured by C7 aptamer seq.2888.49 in patients without (orange) or with 6-month Long Covid (red), during acute COVID-19 (left) and at 6-month follow-up (right). Comparison of all patients (left panel), and mild versus severe cases (right panel). (C) C7 complexes in healthy controls, mild or severe COVID-19 patients, at acute COVID-19 (left) and 6-month follow-up (right). (D) C7 complexes in patients with no Long Covid (symptom duration < 1 month), Long Covid recovered before 6-month follow-up, or 6-month Long Covid, at 6-month
    Complete Blood Counts Total C7, supplied by Assaypro, used in various techniques. Bioz Stars score: 91/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complement+functional+screen+elisa+kit/Human+Complement+C7+AssayMax+ELISA+Kit/pm38236961-397-9-14
    Average 91 stars, based on 3 article reviews
    complete blood counts total c7 - by Bioz Stars, 2026-10
    91/100 stars

    Images

    1) Product Images from "Persistent complement dysregulation with signs of thromboinflammation in active Long Covid."

    Article Title: Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.

    Journal: Science (New York, N.Y.)

    doi: 10.1126/science.adg7942

    Fig. 2. Reduced levels of complement component 7 complexes in active Long Covid. (A) Schematic of terminal complement complexes. (B) Complement component 7 (C7) complexes in log10-transformed relative fluorescence units (log10RFU), measured by C7 aptamer seq.2888.49 in patients without (orange) or with 6-month Long Covid (red), during acute COVID-19 (left) and at 6-month follow-up (right). Comparison of all patients (left panel), and mild versus severe cases (right panel). (C) C7 complexes in healthy controls, mild or severe COVID-19 patients, at acute COVID-19 (left) and 6-month follow-up (right). (D) C7 complexes in patients with no Long Covid (symptom duration < 1 month), Long Covid recovered before 6-month follow-up, or 6-month Long Covid, at 6-month
    Figure Legend Snippet: Fig. 2. Reduced levels of complement component 7 complexes in active Long Covid. (A) Schematic of terminal complement complexes. (B) Complement component 7 (C7) complexes in log10-transformed relative fluorescence units (log10RFU), measured by C7 aptamer seq.2888.49 in patients without (orange) or with 6-month Long Covid (red), during acute COVID-19 (left) and at 6-month follow-up (right). Comparison of all patients (left panel), and mild versus severe cases (right panel). (C) C7 complexes in healthy controls, mild or severe COVID-19 patients, at acute COVID-19 (left) and 6-month follow-up (right). (D) C7 complexes in patients with no Long Covid (symptom duration < 1 month), Long Covid recovered before 6-month follow-up, or 6-month Long Covid, at 6-month

    Techniques Used: Transformation Assay, Fluorescence, Comparison

    Fig. 8. Predictive and diagnostic models of Long Covid. (A) Overview of model training strategy by nested cross-validation. For each fold, models were trained on training portion of data with hyperparameters adjusted on the basis of validation set. Each trained model was evaluated on an unseen test set. [Created with BioRender.com] (B) Area under the receiver operating characteristics curve (AUROC) of a random forest predictor using up to 61 uncorrelated protein measurements, 2 protein ratios, 14 general clinical variables, top selected features of 6-month Long Covid prediction selected on training data [age, body mass index (BMI), C5bC6/C7 complexes, and vWF/ADAMTS13 ratio], or age and BMI alone.
    Figure Legend Snippet: Fig. 8. Predictive and diagnostic models of Long Covid. (A) Overview of model training strategy by nested cross-validation. For each fold, models were trained on training portion of data with hyperparameters adjusted on the basis of validation set. Each trained model was evaluated on an unseen test set. [Created with BioRender.com] (B) Area under the receiver operating characteristics curve (AUROC) of a random forest predictor using up to 61 uncorrelated protein measurements, 2 protein ratios, 14 general clinical variables, top selected features of 6-month Long Covid prediction selected on training data [age, body mass index (BMI), C5bC6/C7 complexes, and vWF/ADAMTS13 ratio], or age and BMI alone.

    Techniques Used: Diagnostic Assay, Biomarker Discovery

    Related Articles

    Enzyme-linked Immunosorbent Assay:

    Article Title: Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.
    Article Snippet: .. Protein and heme quantifications by ELISA, functional assays, and complete blood counts Total C7 (AssayPro; CatEC7101-1), sC5b-9 (Quidel; Cat#A020), factor Ba (Quidel; Cat#A033), CH50 Equivalent (Quidel;Cat#A018),andvWF(AssayPro; Cat#CEV20301) were measured by applying commercially available ELISAs on patient sera analyzedwith theSomaScanplatform(39healthy controls, and 113 COVID-19 patients at acute COVID-19 and 6-month follow-up), according to the manufacturers’ instructions. vWF measurements were calibrated against WHO controls. .. Factor Ba purified from human serum (CompTech; Cat#A154) was used as positive control.

    Functional Assay:

    Article Title: Persistent complement dysregulation with signs of thromboinflammation in active Long Covid.
    Article Snippet: .. Protein and heme quantifications by ELISA, functional assays, and complete blood counts Total C7 (AssayPro; CatEC7101-1), sC5b-9 (Quidel; Cat#A020), factor Ba (Quidel; Cat#A033), CH50 Equivalent (Quidel;Cat#A018),andvWF(AssayPro; Cat#CEV20301) were measured by applying commercially available ELISAs on patient sera analyzedwith theSomaScanplatform(39healthy controls, and 113 COVID-19 patients at acute COVID-19 and 6-month follow-up), according to the manufacturers’ instructions. vWF measurements were calibrated against WHO controls. .. Factor Ba purified from human serum (CompTech; Cat#A154) was used as positive control.



    Similar Products

    total complement functional screen elisa kit  (Eagle Biosciences)
    92
    Eagle Biosciences total complement functional screen elisa kit
    Total Complement Functional Screen Elisa Kit, supplied by Eagle Biosciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complement+functional+screen+elisa+kit/Total+complement+functional+screen+ELISA/pm37887754-49-11-17
    Average 92 stars, based on 1 article reviews
    total complement functional screen elisa kit - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier
    complement functional screen elisa kit  (Eagle Biosciences)
    92
    Eagle Biosciences complement functional screen elisa kit
    Complement Functional Screen Elisa Kit, supplied by Eagle Biosciences, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/complement+functional+screen+elisa+kit/Total+complement+functional+screen+ELISA/pm37887754-49-12-17
    Average 92 stars, based on 1 article reviews
    complement functional screen elisa kit - by Bioz Stars, 2026-10
    92/100 stars
    		  Buy from Supplier

    Image Search Results